Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Benitec Biopharma (BNTC) Current Leases: 2020-2024

Historic Current Leases for Benitec Biopharma (BNTC) over the last 5 years, with Jun 2024 value amounting to $284,000.

  • Benitec Biopharma's Current Leases rose 18.49% to $346,000 in Q1 2025 from the same period last year, while for Mar 2025 it was $346,000, marking a year-over-year increase of 18.49%. This contributed to the annual value of $284,000 for FY2024, which is 3.27% up from last year.
  • Per Benitec Biopharma's latest filing, its Current Leases stood at $284,000 for FY2024, which was up 3.27% from $275,000 recorded in FY2023.
  • In the past 5 years, Benitec Biopharma's Current Leases ranged from a high of $284,000 in FY2024 and a low of $192,000 during FY2020.
  • Its 3-year average for Current Leases is $270,333, with a median of $275,000 in 2023.
  • Data for Benitec Biopharma's Current Leases shows a peak YoY increased of 18.31% (in 2022) over the last 5 years.
  • Yearly analysis of 5 years shows Benitec Biopharma's Current Leases stood at $192,000 in 2020, then grew by 10.94% to $213,000 in 2021, then grew by 18.31% to $252,000 in 2022, then climbed by 9.13% to $275,000 in 2023, then grew by 3.27% to $284,000 in 2024.